Delivery Order SPE2DB22D2009-SPE2DB24FL9BN

Award Date 4/8/24
Potential Completion Date 4/9/24
Potential Value $8.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $14,914.29 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TREMFYA 100 MG/ML INJECTORML pharmaceutical products. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $53,184.06, is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a medical supply item. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 12, 2024. This award is not designated as a set-aside contract....
The U.S. Defense Logistics Agency (DLA) awarded a $27,203.88 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of TREMFYA 100 MG/ML INJECTORML pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies from...
This federal contract award, valued at $20,437.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TREMFYA 100 MG/ML SYRINGE/ML, a medical product, under a Firm Fixed Price delivery order. The contract has a completion date of December 27, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of TREMFYA 100 MG/ML INJECTOR medication to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $8,336.45 and an ultimate completion date of August 26, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business category. Amerisourcebergen, through its Corporate Office...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,387.68 firm fixed-price delivery order is for the supply of TREMFYA 100 MG/ML SYRINGEML, a specialty medication. The contract has a completion date of February 24, 2025 and does not include any set-aside requirements. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $29,153.94 firm fixed price delivery order for the pharmaceutical product TREMFYA 100 MG/ML INJECTORML. This order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense military...
This federal contract award, valued at $35,304.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a specialty medication, with a completion date of April 18, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This is a $16,533.74 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TREMFYA 100 MG/ML syringes and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $11,095.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of TREMFYA 100 MG/ML SYRINGEML, a medical product. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB24FL9BN
    Delivery Order

The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of TREMFYA 100 MG/ML SYRINGEML. This $8,266.87 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp, as the prime contractor, has previously received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities. The current award is not associated with any set-aside designation. Additionally, AmerisourceBergen Drug Corp holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications, valued at up to $750,000 through May 2024. The company also has an indefinite delivery contract with DLA, valued at up to $999,999,999.00, to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 7/8/24, 9:34 AM